Sequential Time to Positivity as a Prognostic Indicator in Staphylococcus aureus Bacteremia

被引:1
|
作者
Comba, Isin Y. [1 ,3 ]
Go, John Raymond [1 ]
Vaillant, James [1 ]
O'Horo, John C. [1 ]
Stevens, Ryan W. [2 ]
Palraj, Raj [1 ]
Abu Saleh, Omar [1 ,3 ]
机构
[1] Mayo Clin, Div Publ Hlth Infect Dis & Occupat Med, Dept Med, Rochester, MN USA
[2] Mayo Clin, Dept Pharm, Rochester, MN USA
[3] Mayo Clin, Div Publ Hlth Infect Dis & Occupat Med, 200 First St SW, Rochester, MN 55905 USA
来源
OPEN FORUM INFECTIOUS DISEASES | 2024年 / 11卷 / 04期
关键词
bacteremia; blood cultures; infective endocaditis; Staphylococcus aureus; time to positivity; BLOOD CULTURES; PREDICTOR; MORTALITY; INFECTIONS; MANAGEMENT; ADULTS;
D O I
10.1093/ofid/ofae173
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: We aimed to determine the factors associated with sequential blood culture time to positivity (STTP) and validate the previously defined time to positivity (TTP) ratio threshold of 1.5 in predicting adverse disease outcomes and mortality of Staphylococcus aureus bacteremia (SAB). Methods: We conducted an observational study of adult patients with SAB. The TTP ratio was calculated by dividing the TTP of the second blood culture by that of the first. Results: Of 186 patients, 69 (37%) were female, with a mean age of 63.6 years. Median TTP was 12 hours (interquartile range [IQR], 10-15 hours) from the initial and 21 hours (17-29) from sequential blood cultures. Methicillin-resistant S aureus (MRSA)-infected patients had significantly shorter STTPs (P < .001) and lower TTP ratios (P < .001) compared to patients with methicillin-susceptible S aureus (MSSA). A significant correlation between initial and STTP was observed in patients with MRSA (r = 0.42, P = .002) but not in those with MSSA. A higher rate of native valve endocarditis (NVE) significantly correlated with a TTP ratio of <= 1.5 (odds ratio, 2.65 [95% confidence interval, 1.3-5.6]; P = .01). The subgroup having an initial TTP <12 hours combined with a TTP ratio <= 1.5 showed the highest prevalence of NVE. Conclusions: The STTP varies based on methicillin susceptibility of S aureus isolate. This study suggests a potential clinical utility of the STTP to identify patients at a higher risk of NVE. However, prospective studies are required to validate these findings.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] STAPHYLOCOCCUS AUREUS MENINGITIS AND BACTEREMIA
    AARON, RS
    NEW YORK STATE JOURNAL OF MEDICINE, 1951, 51 (08) : 1059 - 1060
  • [32] Persistent Staphylococcus aureus Bacteremia
    Huang, Po-Han
    Chen, Nai-Ching
    Ho, Tzung-Yo
    Chen, Chien-Liang
    INTERNAL MEDICINE, 2015, 54 (05) : 541 - 542
  • [33] PANCARDITIS AND BACTEREMIA BY STAPHYLOCOCCUS AUREUS
    Molinero Abad, S.
    Cuesta Lasso, M.
    Cabo Magadan, R.
    Duenas Gutierrez, C. J.
    Portillo Tunon, V.
    Iglesias, E.
    Blanco Martinez de Morentin, A.
    Salazar Thierold, E.
    Quinones, M.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2013, 41 : S9 - S9
  • [34] Echocardiography in Staphylococcus aureus bacteremia
    Guzzo, JA
    Simpson, RJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (06) : 1443 - 1444
  • [35] Antiplatelet Therapy in Staphylococcus aureus Bacteremia: No Time Like the Past?
    Mourad, Ahmad
    Holland, Thomas L.
    Turner, Nicholas A.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2022, 66 (06)
  • [36] A Prognostic Model of Persistent Bacteremia and Mortality in Complicated Staphylococcus aureus Bloodstream Infection
    Guimaraes, Alessander O.
    Cao, Yi
    Hong, Kyu
    Mayba, Oleg
    Peck, Melicent C.
    Gutierrez, Johnny
    Ruffin, Felicia
    Carrasco-Triguero, Montserrat
    Dinoso, Jason B.
    Clemenzi-Allen, Angelo
    Koss, Catherine A.
    Maskarinec, Stacey A.
    Chambers, Henry F.
    Fowler, Vance G., Jr.
    Baruch, Amos
    Rosenberger, Carrie M.
    CLINICAL INFECTIOUS DISEASES, 2019, 68 (09) : 1502 - 1511
  • [37] Prognostic Power of Pathogen Cell-Free DNA in Staphylococcus aureus Bacteremia
    Guimaraes, Alessander O.
    Gutierrez, Johnny
    Maskarinec, Stacey A.
    Cao, Yi
    Hong, Kyu
    Ruffin, Felicia
    Carrasco-Triguero, Montserrat
    Peck, Melicent C.
    Fowler, Vance G.
    Baruch, Amos
    Rosenberger, Carrie M.
    OPEN FORUM INFECTIOUS DISEASES, 2019, 6 (04):
  • [38] Persistent Staphylococcus aureus bacteremia: Incidence and outcome trends over time
    Khatib, Riad
    Johnson, L. B.
    Sharma, M.
    Fakih, M. G.
    Ganga, R.
    Riederer, K.
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2009, 41 (01) : 4 - 9
  • [39] Sulfathiazole therapy of staphylococcus aureus bacteremia
    Rammelkamp, CH
    Keffer, CS
    NEW ENGLAND JOURNAL OF MEDICINE, 1940, 223 : 877 - 885
  • [40] STAPHYLOCOCCUS-AUREUS BACTEREMIA IN THE ELDERLY
    GLASER, JB
    DICHTER, M
    AMERICAN JOURNAL OF MEDICINE, 1990, 88 (05): : 554 - 555